Changes of refractory periods in the A-V conduction system induced by antiarrhythmic drugs. A study using His bundle recordings.
作者信息
Schlepper M, Neuss H
出版信息
Acta Cardiol. 1974;Suppl 18:269-77.
PMID:4547475
Abstract
摘要
相似文献
1
Changes of refractory periods in the A-V conduction system induced by antiarrhythmic drugs. A study using His bundle recordings.
Acta Cardiol. 1974;Suppl 18:269-77.
2
Action of antiarrhythmic drugs on His bundle electrogram and sinus node function.
Acta Cardiol. 1974;Suppl 18:251-67.
3
4
A new clinical and experimental model for studying the effects of antiarrhythmic drugs upon automaticity and conduction.
Acta Cardiol. 1974;Suppl 18:289-96.
5
Electrophysiology of atropine.阿托品的电生理学
Cardiovasc Res. 1975 Jan;9(1):73-80. doi: 10.1093/cvr/9.1.73.
6
[Action of anti-arrhythmia agents on intracardiac conduction].[抗心律失常药物对心内传导的作用]
Acta Cardiol. 1974;Suppl 18:241-50.
7
8
Electrophysiological effects of the antiarrhythmic agent QX-572 in the human heart with special reference to rate-induced changes in effective refractory periods.抗心律失常药物QX - 572对人体心脏的电生理效应，特别提及心率诱导的有效不应期变化。
Cardiovasc Res. 1975 Jan;9(1):81-94. doi: 10.1093/cvr/9.1.81.
9
[AV-conduction system under high doses of ajmaline binitrate and sparteine. Animal experiments using bundle of His electrography].
Verh Dtsch Ges Inn Med. 1975;81:194-6.
10
Effects of atropine on atrial refractoriness and its dispersion in humans.
Int J Clin Pharmacol Ther Toxicol. 1984 May;22(5):254-8.
引用本文的文献
1
QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.QT间期延长药物：其致心律失常风险的机制及临床相关性
Cardiovasc Drugs Ther. 1991 Apr;5(2):515-30. doi: 10.1007/BF03029779.
2
[Drug therapy of tachyarrhythmias (author's transl)].快速性心律失常的药物治疗（作者译）
Klin Wochenschr. 1978 Feb 15;56(4):153-68. doi: 10.1007/BF01705379.
Zotero 插件